Membranous Nephropathy
What's New
Last Posted: Dec 11, 2024
- Trends and the Role of Gene-Environment Interactions in Idiopathic Membranous Nephropathy in Northern China.
Wanyin Hou, et al. American journal of nephrology 2024 0 1-17 - Association of 10 Polymorphisms in PLA2R1 and HLA DQA1 Genes with Primary Membranous Nephropathy Risk: A Meta-Analysis and a Meta-Regression.
Tarak Dhaouadi, et al. Biomarker insights 2024 0 11772719241259602 - Meta-analysis of the effects of CYP3A5*3 gene polymorphisms on tacrolimus blood concentration and effectiveness in Chinese patients with membranous nephropathy.
Xiaona Dai, et al. Frontiers in pharmacology 2024 0 1385322 - The causal association of specific gut microbiota on the risk of membranous nephropathy: a Mendelian randomization study.
Qiqi Ma, et al. International urology and nephrology 2024 0 - Machine learning model to estimate probability of remission in patients with idiopathic membranous nephropathy.
Lijin Duo et al. Int Immunopharmacol 2023 125(Pt A) 111126 - Clinical Predictive Value of Phospholipase A2 Receptor Gene Polymorphism Combined with Subclass of Immunoglobulin G in Renal Tissues for Membranous Nephropathy.
Chunyang Ji, et al. Alternative therapies in health and medicine 2023 0 - Primary membranous nephropathy in two siblings with one combined with anti-glomerular basement membrane disease: a case report.
Yan-Jiao Cheng, et al. BMC nephrology 2023 0 (1) 183 - A Genetic Risk Score Distinguishes Different Types of Autoantibody-Mediated Membranous Nephropathy.
Sanjana Gupta, et al. Glomerular diseases 2023 0 (1) 116-125 - Association between PLA2R gene polymorphism and idiopathic membranous nephropathy in Heilongjiang Chinese.
Tian Tian, et al. Annals of translational medicine 2023 0 (3) 148 - Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype.
Chen Dhruti P, et al. Clinical journal of the American Society of Nephrology : CJASN 2023 0 (3) 337-343
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: